Dr. Karen Onel, MD
Claim this profileHospital for Special Surgery
Studies Arthritis
Studies Rheumatoid Arthritis
5 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Karen Onel, MD is currently running
tcVNS
for Juvenile Arthritis
The study is a multicenter, double-blind, sham-controlled trial to evaluate the safety and effectiveness of tcVNS on pain and inflammation associated with JIA. tcVNS is administered with a device that gives off mild electrical impulses through the skin to stimulate the vagus nerve. Part of the vagus nerve and its branches are located in the head and neck. For this study, the impulses will be administered in areas overlying the vagus nerve using a small electrode. The electrode helps to conduct the stimulation through the skin. This stimulation triggers a chemical response through the nerves and has been found to be effective in reducing pain and inflammation in several diseases. The primary objective of this study is to determine the effect of tcVNS on JIA ACR 50 in participants with active JIA. The components of the active and sham tcVNS devices, utilizing the Roscoe Medical TENS 7000, have been FDA 510(k)-cleared and have been determined by the IRB to be a nonsignificant risk device.
Recruiting1 award Phase 2
TNFi Therapy Strategies
for Juvenile Spondyloarthritis
This randomized pragmatic trial will generate knowledge about strategies used to de-escalate tumor necrosis factor inhibitor (TNFi) therapy in patients with juvenile spondyloarthritis with sustained inactive disease and are treated at one of the 29 participating pediatric healthcare systems. This open label study will be conducted in the setting of routine clinical care and will compare the risk and timing of flare (Aim 1) and patients' lived experiences (Aim 2) across three arms.
Recruiting1 award N/A10 criteria
More about Karen Onel, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Karen Onel, MD has experience with
- Observational Study
- Moderna MRNA-1273
- BNT162b2
- Ad26.COV2.S
- Transcutaneous Vagus Nerve Stimulation (tcVNS)
- TNFi Treatment
Breakdown of trials Karen Onel, MD has run
Arthritis
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Rheumatic Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Onel, MD specialize in?
Karen Onel, MD focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Karen Onel, MD currently recruiting for clinical trials?
Yes, Karen Onel, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Karen Onel, MD has studied deeply?
Yes, Karen Onel, MD has studied treatments such as Observational Study, Moderna mRNA-1273, BNT162b2.
What is the best way to schedule an appointment with Karen Onel, MD?
Apply for one of the trials that Karen Onel, MD is conducting.
What is the office address of Karen Onel, MD?
The office of Karen Onel, MD is located at: Hospital for Special Surgery, New York, New York 10021 United States. This is the address for their practice at the Hospital for Special Surgery.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.